Grant S - Search Results

1

Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation.

Dasmahapatra G, Yerram N, Dai Y, Dent P, Grant S. Dasmahapatra G, et al. Among authors: grant s. Clin Cancer Res. 2007 Jul 15;13(14):4280-90. doi: 10.1158/1078-0432.CCR-07-0835. Clin Cancer Res. 2007. Retraction in: Clin Cancer Res. 2016 Oct 1;22(19):4959. doi: 10.1158/1078-0432.CCR-16-1914. PMID: 17634558 Retracted.

2

Altered expression of cell cycle related genes including c-myb in a subclone of HL-60 that exhibits reversible differentiation.

Boise LH, Grant S, Westin EH. Boise LH, et al. Among authors: grant s. Cell Growth Differ. 1992 Jan;3(1):53-61. Cell Growth Differ. 1992. PMID: 1318070

3

Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.

Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA. Grant S, et al. Cancer Res. 1992 Nov 15;52(22):6270-8. Cancer Res. 1992. PMID: 1423273

4

Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.

Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S. Jarvis WD, et al. Among authors: grant s. Cancer Res. 1994 Apr 1;54(7):1707-14. Cancer Res. 1994. PMID: 7511048

5

Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin.

Fornari FA Jr, Jarvis WD, Grant S, Orr MS, Randolph JK, White FK, Mumaw VR, Lovings ET, Freeman RH, Gewirtz DA. Fornari FA Jr, et al. Among authors: grant s. Cell Growth Differ. 1994 Jul;5(7):723-33. Cell Growth Differ. 1994. PMID: 7947387

6

Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.

Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD. Grant S, et al. Oncol Res. 1994;6(2):87-99. Oncol Res. 1994. PMID: 7949469

7

G1 cell cycle arrest and apoptosis are induced in NIH 3T3 cells by KN-93, an inhibitor of CaMK-II (the multifunctional Ca2+/CaM kinase).

Tombes RM, Grant S, Westin EH, Krystal G. Tombes RM, et al. Among authors: grant s. Cell Growth Differ. 1995 Sep;6(9):1063-70. Cell Growth Differ. 1995. PMID: 8519682

8

Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.

Rao AS, Freemerman AJ, Jarvis WD, Chelliah J, Bear HD, Mikkelsen R, Grant S. Rao AS, et al. Among authors: grant s. Leukemia. 1996 Jul;10(7):1150-8. Leukemia. 1996. PMID: 8683995

9

Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).

Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD. Grant S, et al. Cell Growth Differ. 1996 May;7(5):603-13. Cell Growth Differ. 1996. PMID: 8732670

10

Induction of apoptotic DNA fragmentation and c-jun downregulation in human myeloid leukemia cells by the permeant Ca2+ chelator BAPTA/AM.

Grant S, Freemerman AJ, Gregory PC, Martin HA, Turner AJ, Mikkelsen R, Chelliah J, Yanovich S, Jarvis WD. Grant S, et al. Oncol Res. 1995;7(7-8):381-92. Oncol Res. 1995. PMID: 8747601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,824 results

Search Page

Filters